- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Elscint’s VariCam approved in Japan
Japanese regulatory authorities have approved Elscint's VariCamadjustable-angle dual-head gamma camera for marketing in thatcountry. VariCam will be sold in Japan by Philips under a dealbetween the companies signed last year (SCAN 11/6/96). VariCamwill
Japanese regulatory authorities have approved Elscint's VariCamadjustable-angle dual-head gamma camera for marketing in thatcountry. VariCam will be sold in Japan by Philips under a dealbetween the companies signed last year (SCAN 11/6/96). VariCamwill be the first Elscint product marketed in Japan, accordingto president and CEO Jonathan Adereth.
VariCam will take on products from Toshiba as well as Shimadzu,which markets Picker gamma cameras. Those companies dominate theJapanese nuclear medicine market, but neither firm has a variable-anglesystem. ADAC Laboratories, which does have a variable-angle camera,is still ramping up its presence in Japan after its dual-headproducts were approved in September (SCAN 10/9/96). ADAC is representedin Japan by Sumitomo Metal Industries.
Can AI Enhance CT Detection of Incidental Extrapulmonary Abnormalities and Prediction of Mortality?
September 18th 2024Emphasizing multi-structure segmentation and feature extraction from chest CT scans, an emerging AI model demonstrated an approximately 70 percent AUC for predicting significant incidental extrapulmonary findings as well as two-year and 10-year all-cause mortality.
Comparing Digital Breast Tomosynthesis to Digital Mammography: What a Long-Term Study Reveals
September 17th 2024In a study involving over 272,000 breast cancer screening exams, digital breast tomosynthesis (DBT) had a higher breast cancer detection rate and a lower rate of advanced cancer presentation at the time of diagnosis in comparison to digital mammography.
Can Radiomics Enhance Differentiation of Intracranial Aneurysms on Computed Tomography Angiography?
September 17th 2024Radiomics models offered a pooled AUC of 86 percent for differentiating between ruptured and unruptured intracranial aneurysms, according to a recently published meta-analysis.
